Gal Kelmer

Dr. Gal Kelmer

Hebrew University of Jerusalem, Jerusalem, Israel

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2019 in Equine Veterinary Journal
Verified
Journal Article
Closed access
PDF file
HMH. H. Mandel
H. H. Mandel
GSG. A. Sutton
G. A. Sutton
EAE. Abu
E. Abu
GKGal Kelmer
Gal Kelmer

8 June 2016 in Veterinary Surgery
Verified
Journal Article
Closed access
PDF file
GOGil L. Oreff
Gil L. Oreff
RDRoee Dahan
Roee Dahan
ATAmos J. Tatz
Amos J. Tatz
TRTal Raz
Tal Raz
MBMalka Britzi
Malka Britzi
GKGal Kelmer
Gal Kelmer

19 December 2020 in Equine Veterinary Journal
Verified
Journal Article
Closed access
PDF file
KGKajsa Gustafsson
Kajsa Gustafsson
ATAmos J. Tatz
Amos J. Tatz
RSRoni A. Slavin
Roni A. Slavin
GSGila A. Sutton
Gila A. Sutton
RDRoee Dahan
Roee Dahan
GKGal Kelmer
Gal Kelmer

30 July 2014 in Journal of Veterinary Pharmacology and Therapeutics
Verified
Journal Article
Closed access
PDF file
GKGal Kelmer
Gal Kelmer
ATA. J. Tatz
A. J. Tatz
SFS. Famini
S. Famini
TBT. Bdolah‐Abram
T. Bdolah‐Abram
SSS. Soback
S. Soback
MBM. Britzi
M. Britzi

11 February 2020 in Animals
Verified
Journal Article
Open access
PDF file
ATAnat Shnaiderman Torban
Anat Shnaiderman Torban
SNShiri Navon-Venezia
Shiri Navon-Venezia
ZDZiv Dor
Ziv Dor
YPYossi Paitan
Yossi Paitan
HAHaia Arielly
Haia Arielly
Amir SteinmanAmir Steinman
Amir Steinman
We aimed to investigate the prevalence, molecular characteristics and risk factors of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E) shedding in horses. A prospective study included three cohorts: (i) farm horses (13 farms, n = 192); (ii) on hospital admission (n = 168) and; (iii) horses hospitalized for ≥72 h re-sampled from cohort (ii) (n = 86). Enriched rectal swabs were plated, ESBL-production was confirmed (Clinical and Laboratory Standards Institute (CLSI)) and genes were identified (polymerase chain reaction (PCR)). Identification and antibiotic susceptibility were determined (Vitek-2). Medical records and owners’ questionnaires were analyzed. Shedding rates increased from 19.6% (n = 33/168) on admission to 77.9% (n = 67/86) during hospitalization (p < 0.0001, odds ratio (OR) = 12.12). Shedding rate in farms was 20.8% (n = 40/192), significantly lower compared to hospitalized horses (p < 0.0001). The main ESBL-E species (n = 192 isolates) were E. coli (59.9%, 115/192), Enterobacter sp. (17.7%, 34/192) and Klebsiella pneumoniae (13.0%, 25/192). The main gene group was CTX-M-1 (56.8%). A significant increase in resistance rates to chloramphenicol, enrofloxacin, gentamicin, nitrofurantoin, and trimethoprim-sulpha was identified during hospitalization. Risk factors for shedding in farms included breed (Arabian, OR = 3.9), sex (stallion, OR = 3.4), and antibiotic treatment (OR = 9.8). Older age was identified as a protective factor (OR = 0.88). We demonstrated an ESBL-E reservoir in equine cohorts, with a significant ESBL-E acquisition, which increases the necessity to implement active surveillance and antibiotic stewardship programs.

4 June 2016 in Veterinary Record
Verified
Journal Article
Open access
PDF file
GKGal Kelmer
Gal Kelmer
Click on the article title to read more.